52 results for

Dátum 2018.10.22. 9:34

Privacy Policy Janssen Phamaceutica N.V. cares about your privacy and wants you to be familiar with how we collect, use, and disclose information. This Privacy Policy describes our practices in...

Dátum 2018.10.11. 19:26

HONEUR’s principles Do you want to know more about HONEUR’s network principles? Check it out here.

Dátum 2018.09.20. 19:41

Real World Data and Real World Evidence – What’s the difference? Real World Data (RWD) is health data, usually created by healthcare professionals and also by patients, as part of routine health...

Dátum 2018.09.17. 19:29

HONEUR Meeting

Dátum 2018.09.21. 7:51

First site on board! 27/08/2018 We are pleased to announce that the first site was contracted to the HONEUR network: Leicester Royal Infirmary is represented by Dr Mamta Garg, who is actively...

Dátum 2018.09.17. 15:50

Didn’t find the answer to your question here? Feel free to contact us via e-mail We will use your information in accordance with our Privacy Policy to respond to your inquiries and fulfill your...

Dátum 2018.09.17. 15:54

This Q&A has been prepared to answer questions about HONEUR and related topics.

Dátum 2018.10.22. 9:11

Legal Notice All content of this Internet site is owned or controlled by Janssen Pharmaceutica N.V. and is protected by worldwide copyright laws. You may download content only for your personal use...

Dátum 2018.10.09. 12:42

Go to public sitemap

Dátum 2018.09.14. 6:07

Home Become a member About News & Events Q&A Sitemap Privacy policy Legal notice Cookie policy

Dátum 2018.09.17. 19:23

ASH Abstract accepted 27/09/2018 Our abstract “HONEUR (Haematology Outcomes Network in Europe) – A Federated Model to support Real World Data Research in Haematology” has been accepted at the...

Dátum 2018.11.20. 15:34

HONEUR: Second Site On Board! 05/10/2018 We are pleased to announce that we have signed the accession agreement to project HONEUR with Prof. Hajek from the Registry of Monoclonal Gammopathies (RMG)...

Dátum 2018.09.21. 7:38

HONEUR wins Atlas Award 23/10/2018 For the second time, the Janssen EMEA Atlas Award was presented during the RWE Meeting held in Belgium on 23-24 October. The Award recognises excellence in RWE...

Dátum 2019.02.04. 19:24

CP-73766

Dátum 2018.10.19. 16:51

This site is published by Janssen Pharmaceutica N.V., which is solely responsible for its content. This site is intended for the use of our visitors in Europe, the Middle East and Africa. Last...

Dátum 2018.10.11. 19:32

RWE in practice Sweden – Since 1998, Sweden's national Cataract Registry has collected nationwide data on postoperative endophthalmitis (PE), which, although rare, results in blindness in between...

Dátum 2018.09.17. 12:47

Our Mission To create a secure, collaborative platform that enables participants across Europe to liberate the transformational potential of Real World Data. Our Vision We want to help create a...

Dátum 2019.01.30. 10:56

Terms of Use

Dátum 2018.09.17. 15:53

What is HONEUR? HONEUR (Haematology Outcomes Network in Europe) is a new, Janssen-led collaboration amongst data centres in Europe, working together to scale up research on haematological...

Dátum 2018.09.21. 7:07

Join the network To join the HONEUR network, only few prerequisites are needed. Basically, any registry, hospital, physician association or any scientific institute with a dataset on patients with...